Skip to main content Skip to main navigation menu Skip to site footer
Page Header Logo
  • Home
  • About
    • About the Journal
    • Aims & scope
    • Editorial Board
    • Contact Information
  • Current
  • Archives
  • Indexing & Abstracting
  • For Authors
    • Author Guidelines
    • Peer Review Policy
    • Ethical Consideration
    • Publication Ethics and Malpractice Statement
    • Submissions
Search
  • Register
  • Login
  1. Home /
  2. Search

Advanced filters
A Double-Blind, Randomized Comparison Study between Zytux™ vs MabThera® in Treatment of CLL with FCR Regimen: Non-Inferiority Clinical Trial
Gholamreza Toogeh, Mohammad Faranoush, Seyed Mohsen Razavi, Hassan Jalaeikhoo, Abolghasem Allahyari, Mohammad Reza Ravanbod, Fariba Zarrabi, Vahid Fallahazad, Ehsan Rezaei Darzi, Shadi Sadat Alizadeh Fard
Published: 2018-04-05
JAK2V617F Allele Burden Measurement in Peripheral Blood of Iranian Patients with Myeloproliferative Neoplasms and Effect of Hydroxyurea on JAK2V617F Allele Burden
Shirin Ferdowsi, Seyed H Ghaffari, Naser Amirizadeh, Azita Azarkeivan, Kamran Atarodi, Mohammad Faranoush, Gholamreza Toogeh, Reza Shirkoohi, Mohammad Vaezi, Mahtab Maghsoodlu, Kamran Alimoghaddam, Ardeshir Ghavamzadeh, Hossein Teimori Naghadeh
Published: 2016-04-12
Clinical Outcomes of Pediatric Cancer Patients with COVID-19: A Cross-Sectional Study Pediatric Patients with Cancer and COVID-19
Yasaman Arian, Pooya Faranoush, Fahime Ehsanipour, Negin Sadighnia, Ali Elahinia, Mohammad Faranoush
Published: 2024-10-12
Apoptotic Events in Type-I Glanzmann Thrombasthenia Platelets
Ehsan Shahverdi, Corinna Petz, Turadj Hemmati Hemmati2, Alireza Farsinezhad, Ali Heidari, Mohammad Faranoush
Published: 2025-10-16
Pediatric Cancer Registry at MAHAK Pediatric Cancer Treatment and Research Center: A Single-Center Study from Iran
Mohammad Faranoush, Narjes Mehrvar, Yasaman Sadeghi, Maryam Tashvighi, Mardawig Alebouyeh, Azim Mehrvar
Published: 2022-04-03
1 - 5 of 5 items


2024 CiteScore: 1.2

pISSN: 2008-3009
eISSN: 2008-2207

 

Editor-in-Chief:
Ardeshir Ghavamzadeh, MD.

Chairman:
Ghasem Janbabaei

 

This journal is a member of, and subscribes to the principles of, the Committee on Publication Ethics (COPE).

1.2
2024CiteScore
 
 
33rd percentile
Powered by  Scopus

 

SCImago Journal & Country Rank

Make a Submission
Information
  • Publication Fee
  • For Readers
  • For Authors
  • For Librarians
International Journal of Hematology-Oncology and Stem Cell Research (Quarterly), pISSN: 2008-3009, eISSN: 2008-2207
Tehran University of Medical Sciences, Tehran, Iran.

All the work in this journal are licensed under a Creative Commons Attribution-NonCommercial 4.0 International License, which permits any non-commercial use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source.